Market Overview:
The global orthopaedic oncology market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, increasing awareness about orthopaedic oncology treatments, and technological advancements in the field of orthopaedic oncology. The surgery segment is expected to dominate the global orthopaedic oncology market during the forecast period. This can be attributed to the growing demand for surgical treatments for various types of cancers such as bone cancer, soft tissue sarcoma, and head and neck cancers. The chemotherapy segment is projected to grow at a high CAGR during the forecast period owing to its ability to treat various types of cancers effectively. In terms of application, hospitals are expected to account for a major share of the global orthopaedic oncology market during the forecast period.
Product Definition:
Orthopaedic oncology is the study and treatment of cancerous tumors that affect the bones, joints, and muscles. Orthopaedic oncologists are specialists in diagnosing and treating these tumors. Cancerous bone tumors can be very dangerous because they can metastasize (spread) to other parts of the body. Treatment for bone tumors often includes surgery, radiation therapy, and chemotherapy.
Surgery:
Orthopaedic oncology is the branch of surgery that deals with cancer and its treatment. Cancer is a disease caused by uncontrolled growth of cells in the body which invade or spread to other organs, bones, or tissues. The major types of cancers are lung, breast, colorectal ( bowel), stomach, liver & bile ducts (liver), Non-Small Cell Lung Cancer (NSCLC) and melanoma.
Chemotherapy:
Chemotherapy is the use of drugs or chemical substances to treat cancer. Chemotherapy used in orthopaedic oncology can be broadly divided into two categories, first line chemotherapy and second-line chemotherapy. The choice between these depends on factors such as type, location of tumour (infiltrative or non-infiltrative), degree of invasiveness (localized or metastatic), and patient’s response to prior therapy.
Application Insights:
The hospitals segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. This can be attributed to factors such as increasing cancer cases, rising awareness about early diagnosis, and availability of advanced treatment facilities. For instance, according to a study published by NCBI in 2018, it was estimated that around 1 in 8 women aged between 50 and 74 years are likely to develop invasive breast cancer during their lifetime. Thus, there is a huge demand for orthopedic oncology treatments across hospitals globally.
On the other hand, research laboratories accounted for revenue share of 29% in 2017 owing to growing R&D activities pertaining towards development of novel drugs & devices for treating osteosarcoma & Ewing¢â‚¬â„¢s tumor among others. Increasing government funding towards life science research coupled with high potential profit margins has attracted numerous companies toward developing drugs specifically designed for use within these laboratories only (off-label usage).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of orthopedic oncology companies, high adoption rate for advanced therapies, and favorable reimbursement scenario in this region. In addition, rising incidence of osteosarcoma and other bone tumors is expected to fuel regional growth during the forecast period.
Asia Pacific is estimated to witness lucrative growth over the coming years owing to increasing healthcare expenditure by governments as well as private players coupled with rising awareness about advanced treatment options for oncology diseases such as osteosarcoma or Ewing sarcoma. Moreover, rapidly improving healthcare infrastructure along with growing patient disposable income levels are likely to contribute toward higher demand for orthopedic cancer drugs in this region over the next eight years.
Growth Factors:
- Increasing incidence of cancer: The incidence of cancer is increasing at an alarming rate across the globe. This is expected to drive the demand for orthopaedic oncology products and services in the coming years.
- Growing awareness about orthopaedic oncology treatments: There is a growing awareness among people about orthopaedic oncology treatments and their benefits. This is likely to boost the demand for these products and services in the near future.
- Rising number of surgical procedures: The number of surgical procedures being performed for treatment of various types of cancers is increasing rapidly worldwide. This will create a high demand for orthopaedic oncology products and services in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Orthopaedic Oncology Market Research Report
By Type
Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy
By Application
Hospitals, Research Laboratories
By Companies
Stryker Corporation, Amgen Inc., Tyco Electronics UK Holdings Ltd., Accentus Inc., Canon Medical Systems, Siemens Healthineers, MD Anderson Cancer Center, Roche, Novartis AG, Sanofi S.A.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Orthopaedic Oncology Market Report Segments:
The global Orthopaedic Oncology market is segmented on the basis of:
Types
Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker Corporation
- Amgen Inc.
- Tyco Electronics UK Holdings Ltd.
- Accentus Inc.
- Canon Medical Systems
- Siemens Healthineers
- MD Anderson Cancer Center
- Roche
- Novartis AG
- Sanofi S.A.
Highlights of The Orthopaedic Oncology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery
- Chemotherapy
- Radiation Therapy
- Targeted Therapy
- By Application:
- Hospitals
- Research Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Orthopaedic Oncology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Orthopaedic oncology is a specialty of medicine that deals with the diagnosis and treatment of cancer in the bones and joints. Orthopaedic oncologists are specially trained to identify and treat cancers that have spread to the bone or joint. They also work closely with other specialists, such as radiation oncologists, surgeons, pathologists, nurses, pharmacists and social workers to provide comprehensive care for their patients.
Some of the major companies in the orthopaedic oncology market are Stryker Corporation, Amgen Inc., Tyco Electronics UK Holdings Ltd., Accentus Inc., Canon Medical Systems, Siemens Healthineers, MD Anderson Cancer Center, Roche, Novartis AG, Sanofi S.A..
The orthopaedic oncology market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Orthopaedic Oncology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Orthopaedic Oncology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Orthopaedic Oncology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Orthopaedic Oncology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Orthopaedic Oncology Market Size & Forecast, 2018-2028
4.5.1 Orthopaedic Oncology Market Size and Y-o-Y Growth
4.5.2 Orthopaedic Oncology Market Absolute $ Opportunity
Chapter 5 Global Orthopaedic Oncology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Orthopaedic Oncology Market Size Forecast by Type
5.2.1 Surgery
5.2.2 Chemotherapy
5.2.3 Radiation Therapy
5.2.4 Targeted Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Orthopaedic Oncology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Orthopaedic Oncology Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Research Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Orthopaedic Oncology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Orthopaedic Oncology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Orthopaedic Oncology Analysis and Forecast
9.1 Introduction
9.2 North America Orthopaedic Oncology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Orthopaedic Oncology Market Size Forecast by Type
9.6.1 Surgery
9.6.2 Chemotherapy
9.6.3 Radiation Therapy
9.6.4 Targeted Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Orthopaedic Oncology Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Research Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Orthopaedic Oncology Analysis and Forecast
10.1 Introduction
10.2 Europe Orthopaedic Oncology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Orthopaedic Oncology Market Size Forecast by Type
10.6.1 Surgery
10.6.2 Chemotherapy
10.6.3 Radiation Therapy
10.6.4 Targeted Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Orthopaedic Oncology Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Research Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Orthopaedic Oncology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Orthopaedic Oncology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Orthopaedic Oncology Market Size Forecast by Type
11.6.1 Surgery
11.6.2 Chemotherapy
11.6.3 Radiation Therapy
11.6.4 Targeted Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Orthopaedic Oncology Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Research Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Orthopaedic Oncology Analysis and Forecast
12.1 Introduction
12.2 Latin America Orthopaedic Oncology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Orthopaedic Oncology Market Size Forecast by Type
12.6.1 Surgery
12.6.2 Chemotherapy
12.6.3 Radiation Therapy
12.6.4 Targeted Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Orthopaedic Oncology Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Research Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Orthopaedic Oncology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Orthopaedic Oncology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Orthopaedic Oncology Market Size Forecast by Type
13.6.1 Surgery
13.6.2 Chemotherapy
13.6.3 Radiation Therapy
13.6.4 Targeted Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Orthopaedic Oncology Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Research Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Orthopaedic Oncology Market: Competitive Dashboard
14.2 Global Orthopaedic Oncology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Stryker Corporation
14.3.2 Amgen Inc.
14.3.3 Tyco Electronics UK Holdings Ltd.
14.3.4 Accentus Inc.
14.3.5 Canon Medical Systems
14.3.6 Siemens Healthineers
14.3.7 MD Anderson Cancer Center
14.3.8 Roche
14.3.9 Novartis AG
14.3.10 Sanofi S.A.
